Search results for: Policy Analysis
Filter search results
Use of Cost-effectiveness Evidence in US Health Care: Seminar Briefing
1 April 2014
…at Tufts Medical Center. Compared to many other countries, cost-effectiveness analysis plays a limited role in US health care. Just published by OHE, this Seminar Briefing summarises remarks at an…
Spotlight on OHE: Adaptive Pathways, Economic Evaluation, Stated Preferences and Life-cycle Price Modelling
5 November 2014
…Resource Allocation Decisions from Office of Health Economics For additional information please contact Koonal Shah at OHE. Incorporating life-cycle price modelling into pharmaceutical cost-effectiveness analysis OHE’s Michele Pistollato…
OHE is Recruiting for a Head of Operational Research and Data Analytics
15 January 2016
…econometric analysis; and modelling. Candidates must have: A postgraduate degree in Operational Research, Management Science, Statistics or a similar quantitative field Strong data collection and statistical analysis skills Fluency in…
OHE at ISPOR Europe 2016: Risk-sharing, Differential Pricing, the Cancer Drugs Fund, and Patient Reported Outcomes
26 October 2016
…session to illustrate a systematic approach to weighing their applicability and feasibility. Short course: Using Multi-Criteria Decision Analysis in Health Care Decision Making: Approaches & Applications. Sunday, 13:00-17:00, Hall F2…
New OHE Research Paper: The Distribution of the EQ-5D-5L Index in Patient Populations
1 November 2016
…which clusters result from the characteristics of the value sets used to create the index; discuss the implications of our results for statistical analysis of EQ-5D-5L index data. Data from…
How Important are the Differences Between the EQ-5D-5L and EQ-5D-3L Value Sets?
24 March 2017
There are three EQ-5D value sets available for use in cost effectiveness analysis in the UK and/or England: – the UK EQ-5D-3L value set (often called the ‘MVH’ value set)…
OHE is Pleased to Announce the Appointment Two New Economists: Marina Rodes Sanchez and Chris Sampson
12 October 2017
…disease, which has facilitated a variety of methodological and applied research in trial-based cost-effectiveness analysis, meta-analysis, decision analytic modelling, and studies using large data sets. Chris’s research interests include the…
Routine Funding in the UK NHS of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
18 December 2017
…31 December 2016. Our analysis revealed that: NICE evaluated 42% (216) of the 512 new authorisations approved by the European Commission. They recommended 85% of the medicinal products that they…
Comparing Preference-based Outcome Measures for Overactive Bladder: EQ-5D-5L vs OAB-5D
31 January 2018
…on the OAB-5D, a condition-specific preference-based measure (PBM) of health. Cost-utility analysis forms an integral part of health technology assessment (HTA) in a growing number of countries. Societal preferences for…